AI scientist team makes major breakthrough in new drug discovery

The world’s first AI scientist team has successfully discovered a new drug for treating dry age-related macular degeneration (dAMD) in just 2.5 months, marking a significant breakthrough in scientific research powered by AI. Throughout the process, the AI agent named Robin was responsible for hypothesis generation, experimental design, and data analysis, demonstrating a new paradigm in AI-driven scientific discovery. Although the finding still requires further validation, its potential is immense and could revolutionize the speed and methodology of drug development. Looking ahead, AI is expected to extend beyond healthcare into fields such as materials science and climate technology. This achievement has sent shockwaves through the medical community, as AI’s research capabilities are beginning to surpass those of traditional human researchers.